#3 of pharma imports · Intermediates & KSMs
Penicillins & salts (incl. Penicillin-G): imports into India
Tariff line 29411010 · CAS 113-98-4
Imports 2025-26
6,465 t
-25.6% vs 2024-25
Import bill (CIF, before duty)
₹963 cr
Volume growth, 2020-21 to 2025-26
-2.6% a year
Steady
Net imports 2025-26
6,460 t
Exports 5 t
Import volume by financial year
SteadyShow as table
| Year | Imports | Import bill |
|---|---|---|
| 2020-21 | 7,366 t | ₹935 cr |
| 2021-22 | 6,562 t | ₹1,031 cr |
| 2022-23 | 6,381 t | ₹1,713 cr |
| 2023-24 | 7,532 t | ₹2,066 cr |
| 2024-25 | 8,694 t | ₹1,963 cr |
| 2025-26 | 6,465 t | ₹963 cr |
Where it comes from (2025-26)
Share of the import bill
- China94.4%
- Germany3.3%
- Austria1.2%
What's changing
- Aurobindo Pharma's Lyfius Pharma commissioned a 15,000 t/yr Penicillin-G plant in the Kakinada SEZ, Andhra Pradesh, alongside a 3,600 t/yr 6-APA plant (Qule Pharma).Indian Pharma Post, 2 Apr 2024
- As of June 2026, ₹5,210.74 crore had been invested under the bulk-drug PLI scheme (outlay ₹6,940 crore), with 39 projects for 28 APIs and KSMs including Penicillin-G.The Pioneer, 26 Sept 2026
- DGTR opened an anti-dumping investigation into Penicillin-G and its salts from China in late September 2026, on an application by Lyfius Pharma.Open Magazine, 29 Sept 2026
Reported facts with their source. Not a forecast.
Buy or supply penicillins & salts (incl. penicillin-g) in India
Source: Export Import Data Bank, Department of Commerce (DGCI&S data), as published on 10 Nov 2026. The import bill is the total declared value, not a price per kg. How to read these figures.